skye pharma

Skyepharma Plans Joint Development With Novartis

SkyePharma PLC announced an agreement with Novartis Pharma AG to jointly develop a new product for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The product will combine Novartis’ novel long-acting bronchodilator QAB149 with two SkyePharma technologies SkyeHaler(TM), a breath-activated multi-dose dry powder inhaler (MDDPI) device, to be marketed by Novartis as the Read more about Skyepharma Plans Joint Development With Novartis[…]

skye pharma

Skyepharma Begins Requip Ocr Clinical

Skyepharma has initiated Phase III clinical trials of the oral controlled release formulation of GlaxoSmithKline‘s Requip (Ropinirole HCl). The new once daily formulation for Parkinson’s disease has been developed utilizing SkyePharma’s Geomatrix technology. Requip OCR is expected to simplify the treatment regime for patients using this drug, thus improving patient convenience and compliance. The company Read more about Skyepharma Begins Requip Ocr Clinical[…]

skye pharma

Approvable Letter Received For Uroxatral

SkyePharma PLC and Sanofi-Synthelabo have received an “approvable letter” from the US FDA for UroXatral (once-daily formulation of alfuzosin) for the symptomatic treatment of benign prostatic hyperplasia. The formulation utilizes SkyePharma’s proprietary oral drug delivery technology, GEOMATRIX. The New Drug Application for UroXatral was submitted in December 2000 in the United States. Michael Ashton, SkyePharma’s Read more about Approvable Letter Received For Uroxatral[…]

skye pharma

Skyepharma Licenses Dermatology Technology

SkyePharma PLC has licensed rights to three topical drug delivery technologies, Crystalip, DermaStick and the ES-Gel system, from Bioglan Pharma PLC. Under the terms of the agreement SkyePharma has paid $9 million in cash and will obtain certain exclusive development and commercial rights in relation to new products from the Crystalip and DermaStick technologies and Read more about Skyepharma Licenses Dermatology Technology[…]

Purchasing Dragon Pharma LLC Online

NPP 150

Injectable Anabolic Steroid
Primary Chemical Name: Nandrolone Phenylpropionate
Branded by: Dragon Pharma Labs
Pack: 1 X 10 ml (150 mg/ml)

Parabolan 100

Injectable Anabolic Steroid
Basal Substance: Trenbolone Hexahydrobenzylcarbonate
Producer: Dragon Pharmaceutical
Pack: 1 X 10 ml (100 mg/ml)

Oxymetholon - Bulk Price

Administration: Oral
Active Component: Oxymetholone
Producer: Dragon Pharmaceutical
Unit: 10 x 100 tabs (50 mg/pastille)
Price: 10 x $65.00

TriTren 150 - Bulk Price

Administration: Injection
Basic Ingredient: Tri Trenbolone
Produced by: Dragon Pharmaceutical
Amount: 10 x 10 mL vial (150 mg/mL)
Price: 10 x $72.00

Clenbuterol - Cheap Price

Administration: Oral
Base Component: Clenbuterol Hydrochloride
Branded by: Dragon Pharma Labs
Unit: 20 x 100 pills (40 mcg/tab)
Price: 20 x $25

Clenbuterol - Discount Price

Administration: Oral
Prime Ingredient: Clenbuterol Hydrochloride
Producer: Dragon Pharma Labs
Pack: 30 x 100 tabs (40 mcg/tablet)
Price: 30 x $20

Deca 500

Injectable Steroid for Muscle Growth
Basal Component: Nandrolone Decanoate
Manufacturer: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (500 mg/mL)

Cypionat 250

Injectable Steroid for Muscle Growth
Primary Constituent: Testosterone Cypionate
Made by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (250 mg/mL)

1-Test Cyp 200

Injectable Steroid for Muscle Growth
Active Component: Dihydroboldenone Cypionate
Manufacturer: Dragon Pharmaceutical
10 mL Sterile Multi-dose Vial (200 mg/mL)

NPP 150

Injectable Steroid for Muscle Growth
Basal Ingredient: Nandrolone Phenylpropionate
Manufacturer: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (150 mg/mL)

Enantat 400

Primary Substance: Testosterone Enanthate
Made by: Dragon Pharma
Pack: 10 mL vial (400 mg/mL)

Parabolan 100

Basic Chemical Name: Trenbolone Hexahydrobenzylcarbonate
Producer: Dragon Pharma Labs
Amount: 10 x 10 mL vial (100 mg/mL)